Mylan N.V. (MYL) Profit Margin History

Historical gross, operating and net quarterly profit margin for Mylan N.V. (MYL) over the last 10 years. The current net profit margin for Mylan N.V. as of March 19, 2018 is 5.84%.

Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $21.003B $11.908B
Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.